RVMD · Revolution Medicines, Inc. · Held by Funds
$172.29
-4.06 (-2.30%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$37.27B
Shares
216.29M
Volume · Nov 13
2.65M
Avg daily vol (3M)
2.16M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of RVMD by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 13.66% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 2.03% | 4,388,233 |
| Index ETFs | 11.63% | 25,148,867 |
| Active ETFs | 0.48% | 1,038,623 |
| Active funds | 12.22% | 26,420,042 |
| Unclassified | 0.87% | 1,888,618 |
| All registered funds | 27.22% | 58,884,383 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding RVMD
539 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 6,412,413 | $1,200,916,707 | 0.05% | Long | 2026-06-30 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 4,631,150 | $867,321,772 | 0.46% | Long | 2026-06-30 | |
| Growth Fund of America | — | 2,964,768 | $609,467,358 | 0.17% | Long | 2026-08-31 | |
| Fidelity Growth Company Fund | — | 2,472,885 | $508,350,969 | 0.52% | Long | 2026-08-31 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 2,670,853 | $500,197,350 | 1.06% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 2,291,511 | $429,154,180 | 0.44% | Long | 2026-06-30 | |
| VANGUARD HEALTH CARE FUND | — | 1,988,729 | $372,946,349 | 0.98% | Long | 2026-07-31 | |
| MFS Mid Cap Growth Fund | — | 1,558,466 | $320,373,856 | 2.47% | Long | 2026-08-31 | |
| iShares Biotechnology ETF | IBB | 1,349,118 | $252,662,819 | 2.78% | Long | 2026-06-30 | |
| JPMorgan Large Cap Growth Fund | — | 1,166,558 | $218,472,982 | 0.18% | Long | 2026-06-30 | |
| iShares Russell Mid-Cap Growth ETF | IWP | 1,128,977 | $211,434,813 | 0.98% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 972,700 | $199,957,939 | 0.50% | Long | 2026-08-31 | |
| Schwab U.S. Small-Cap ETF | SCHA | 950,220 | $195,336,725 | 0.86% | Long | 2026-08-31 | |
| Fidelity OTC Portfolio | — | 1,002,878 | $188,069,711 | 0.44% | Long | 2026-07-31 | |
| Janus Henderson Enterprise Fund | — | 978,312 | $183,218,271 | 0.82% | Long | 2026-06-30 | |
| Janus Henderson Forty Fund | — | 937,887 | $175,647,477 | 0.74% | Long | 2026-06-30 | |
| Janus Henderson Global Life Sciences Fund | — | 936,558 | $175,398,582 | 3.02% | Long | 2026-06-30 | |
| Select Biotechnology Portfolio | FBIOX | 735,072 | $151,108,751 | 2.40% | Long | 2026-08-31 | |
| iShares Russell Mid-Cap ETF | IWR | 786,979 | $147,385,427 | 0.26% | Long | 2026-06-30 | |
| Fidelity Growth Company K6 Fund | FGKFX | 685,928 | $141,006,219 | 0.50% | Long | 2026-08-31 | |
| iShares Russell 1000 Growth ETF | IWF | 730,570 | $136,821,150 | 0.11% | Long | 2026-06-30 | |
| Fidelity Mid Cap Index Fund | FSMDX | 724,852 | $135,931,496 | 0.26% | Long | 2026-07-31 | |
| Growth Fund | — | 715,338 | $133,968,501 | 0.23% | Long | 2026-06-30 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 690,499 | $129,316,653 | 1.20% | Long | 2026-06-30 | |
| Fidelity Series Growth Company Fund | FCGSX | 587,502 | $120,772,786 | 0.49% | Long | 2026-08-31 | |
| Lord Abbett Growth Leaders Fund | — | 613,872 | $115,119,416 | 1.55% | Long | 2026-07-31 | |
| Schwab U.S. Mid-Cap ETF | SCHM | 552,794 | $113,637,863 | 0.76% | Long | 2026-08-31 | |
| Franklin Dynatech Fund | — | 600,000 | $112,368,000 | 0.37% | Long | 2026-06-30 | |
| Janus Henderson Triton Fund | — | 563,888 | $105,604,945 | 1.78% | Long | 2026-06-30 | |
| Select Health Care Portfolio | — | 505,000 | $103,812,850 | 1.54% | Long | 2026-08-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 494,094 | $101,570,904 | 0.46% | Long | 2026-08-31 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 527,759 | $98,838,706 | 0.67% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 495,491 | $92,795,554 | 0.78% | Long | 2026-06-30 | |
| Fidelity Contrafund | — | 477,800 | $89,482,384 | 0.05% | Long | 2026-06-30 | |
| Federated Hermes MDT Mid Cap Growth Fund | — | 461,570 | $86,558,222 | 1.31% | Long | 2026-07-31 | |
| Fidelity Total Market Index Fund | FSKAX | 381,304 | $78,384,663 | 0.06% | Long | 2026-08-31 | |
| Janus Henderson Research Fund | — | 412,224 | $77,201,311 | 0.26% | Long | 2026-06-30 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 361,340 | $74,280,664 | 1.17% | Long | 2026-08-31 | |
| Janus Henderson Venture Fund | — | 384,421 | $71,994,365 | 1.99% | Long | 2026-06-30 | |
| Janus Henderson Balanced Fund | — | 362,309 | $67,853,230 | 0.24% | Long | 2026-06-30 | |
| iShares MSCI USA Momentum Factor ETF | MTUM | 352,480 | $66,100,574 | 0.26% | Long | 2026-07-31 | |
| Fidelity Advisor Biotechnology Fund | — | 352,200 | $66,048,066 | 3.00% | Long | 2026-07-31 | |
| Janus Henderson Contrarian Fund | — | 348,053 | $65,183,366 | 1.19% | Long | 2026-06-30 | |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND | — | 311,923 | $64,122,011 | 0.12% | Long | 2026-08-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 311,715 | $64,079,253 | 0.06% | Long | 2026-08-31 | |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | — | 297,199 | $55,659,429 | 0.24% | Long | 2026-06-30 | |
| Fidelity Advisor Equity Growth Fund | — | 259,400 | $53,324,858 | 0.41% | Long | 2026-08-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | ITOT | 258,226 | $48,360,565 | 0.05% | Long | 2026-06-30 | |
| Fidelity Large Cap Growth Index Fund | FSPGX | 251,879 | $47,234,869 | 0.11% | Long | 2026-07-31 | |
| Dimensional U.S. Core Equity 2 ETF | DFAC | 240,308 | $45,064,959 | 0.09% | Long | 2026-07-31 |
Showing 1–50 of 539 positions
Key facts
CIK
1628171
CUSIP
76155X100
13F (30d)
560 filings
520 filers
Visit website
Investor relations